Synapse - Works

Results (3382)

Plastic reconstructive procedures

Book Section

Pusic, A. L.; Barakat, R. R.; Cordeiro, P. G.
In Smith, J. R.; Del Priore, G.; Coleman, R. L.; Monaghan, J. M. (Eds.) An Atlas of Gynecologic Oncology: Investigation and Surgery. 3rd ed (2011)

Fulltext@MSK | Save

Phase III randomized study of ipilimumab (IPI) plus dacarbazine (DTIC) versus DTIC alone as first-line treatment in patients with unresectable stage III or IV melanoma

Meeting Abstract

Wolchok, J. D.; Thomas, L.; Bondarenko, I. N.; O'Day, S.; Weber, J. S.; Garbe, C.; Francis, S.; Ibrahim, R. A.; Hoos, A.; Robert, C.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

The novel cytotoxicity of neutrophils in the peripheral blood of breast cancer patients versus women without breast cancer

Meeting Abstract

Granot, Z.; Comen, E. A.; Norton, L.; Benezra, R.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Standardized uptake value (SUV) by positron emission tomography/computed tomography (PET/CT) as a prognostic variable in metastatic breast cancer (MBC)

Meeting Abstract

Jhaveri, K. L.; Ulaner, G.; Fazio, M.; Eaton, A.; Patil, S.; Evangelista, L.; Serna-Tamayo, C.; McArthur, H. L.; Hudis, C.; Morris, P. G.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Axillary node staging for microinvasive breast cancer: Is it justified?

Meeting Abstract

Lyons, J. M.; Stempel, M.; Van Zee, K. J.; Cody, H. S.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Patient characteristics associated with the decision to undergo bilateral prophylactic mastectomy for lobular carcinoma in situ

Meeting Abstract

Muhsen, S.; Junqueira, M. J.; Park, A.; Sung, J. S.; Patil, S.; Oskar, S.; Morrogh, M.; Morrow, M.; King, T. A.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Phase III randomized, open-label, multicenter trial (BRIM3) comparing BRAF inhibitor vemurafenib with dacarbazine (DTIC) in patients with (V600E)BRAF-mutated melanoma

Meeting Abstract

Chapman, P. B.; Hauschild, A.; Robert, C.; Larkin, J. M. G.; Haanen, J. B. A. G.; Ribas, A.; Hogg, D.; O'Day, S.; Ascierto, P. A.; Testori, A.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

OCEANS: A randomized, double-blinded, placebo-controlled phase III trial of chemotherapy with or without bevacizumab (BEV) in patients with platinum-sensitive recurrent epithelial ovarian (EOC), primary peritoneal (PPC), or fallopian tube cancer (FTC)

Meeting Abstract

Aghajanian, C.; Finkler, N. J.; Rutherford, T.; Smith, D. A.; Yi, J.; Parmar, H.; Nycum, L. R.; Sovak, M. A.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Randomized double-blind placebo-controlled international trial of abago-vomab maintenance therapy in patients with advanced ovarian cancer after complete response to first-line chemotherapy: The Monoclonal Antibody Immunotherapy for Malignancies of the Ovary by Subcutaneous Abago-vomab (MIMOSA) trial

Meeting Abstract

Pfisterer, J.; Berek, J. S.; Casado, A.; Cwiertka, K.; Pinter, T.; Pluzanska, A.; Pujade-Lauraine, E.; Scambia, G.; Vermorken, J. B.; Simonelli, C.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Evaluation of circulating tumor cell (CTC) enumeration as an efficacy response biomarker of overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC): Planned final analysis (FA) of COU-AA-301, a randomized, double-blind, placebo-controlled, phase III study of abiraterone acetate (AA) plus low-dose prednisone (P) post docetaxel

Meeting Abstract

Scher, H. I.; Heller, G.; Molina, A.; Kheoh, T. S.; Attard, G.; Moreira, J.; Sandhu, S. K.; Parker, C.; Logothetis, C.; McCormack, R. T.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save